Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by M Akdis and Cezmi Akdis.
M Akdis
Connection Strength
13.528
Cezmi Akdis
  1. COVID-19: A series of important recent clinical and laboratory reports in immunology and pathogenesis of SARS-CoV-2 infection and care of allergy patients. Allergy. 2021 03; 76(3):622-625.
    View in: PubMed
    Score: 0.932
  2. Precision medicine and phenotypes, endotypes, genotypes, regiotypes, and theratypes of allergic diseases. J Clin Invest. 2019 03 11; 129(4):1493-1503.
    View in: PubMed
    Score: 0.813
  3. Gene expression signatures of circulating human type 1, 2, and 3 innate lymphoid cells. J Allergy Clin Immunol. 2019 06; 143(6):2321-2325.
    View in: PubMed
    Score: 0.811
  4. Treatment for food allergy. J Allergy Clin Immunol. 2018 01; 141(1):1-9.
    View in: PubMed
    Score: 0.749
  5. Mechanisms of food allergy. J Allergy Clin Immunol. 2018 01; 141(1):11-19.
    View in: PubMed
    Score: 0.749
  6. Monitoring inflammatory heterogeneity with multiple biomarkers for multidimensional endotyping of asthma. J Allergy Clin Immunol. 2018 01; 141(1):442-445.
    View in: PubMed
    Score: 0.736
  7. Highlights in immune response, microbiome and precision medicine in allergic disease and asthma. Curr Opin Immunol. 2017 Oct; 48:iv-ix.
    View in: PubMed
    Score: 0.736
  8. Specific allergy and asthma prevention coming to an age: A milestone in children. J Allergy Clin Immunol. 2018 02; 141(2):527-528.
    View in: PubMed
    Score: 0.734
  9. The Journal of Allergy and Clinical Immunology: An update on style and substance. J Allergy Clin Immunol. 2017 07; 140(1):60-62.
    View in: PubMed
    Score: 0.723
  10. The future of allergy/immunology: Promising young investigators. J Allergy Clin Immunol. 2017 08; 140(2):384-386.
    View in: PubMed
    Score: 0.721
  11. Type 3 innate lymphoid cells induce proliferation of CD94+ natural killer cells. J Allergy Clin Immunol. 2017 10; 140(4):1156-1159.e7.
    View in: PubMed
    Score: 0.713
  12. Histamine receptors are hot in immunopharmacology. Eur J Pharmacol. 2006 Mar 08; 533(1-3):69-76.
    View in: PubMed
    Score: 0.328
  13. A compendium answering 150 questions on COVID-19 and SARS-CoV-2. Allergy. 2020 10; 75(10):2503-2541.
    View in: PubMed
    Score: 0.223
  14. Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19. Allergy. 2020 07; 75(7):1564-1581.
    View in: PubMed
    Score: 0.223
  15. Human type 2 innate lymphoid cells disrupt skin keratinocyte tight junction barrier by IL-13. Allergy. 2019 12; 74(12):2534-2537.
    View in: PubMed
    Score: 0.208
  16. Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid. J Allergy Clin Immunol. 2019 06; 143(6):2190-2201.e9.
    View in: PubMed
    Score: 0.201
  17. Comparison of regulatory B cells in asthma and allergic rhinitis. Allergy. 2019 04; 74(4):815-818.
    View in: PubMed
    Score: 0.200
  18. Laundry detergents and detergent residue after rinsing directly disrupt tight junction barrier integrity in human bronchial epithelial cells. J Allergy Clin Immunol. 2019 05; 143(5):1892-1903.
    View in: PubMed
    Score: 0.199
  19. Chronic rhinosinusitis: pathogenesis, therapy options, and more. Expert Opin Pharmacother. 2018 11; 19(16):1805-1815.
    View in: PubMed
    Score: 0.198
  20. Precision/Personalized Medicine in Allergic Diseases and Asthma. Arch Immunol Ther Exp (Warsz). 2018 Dec; 66(6):431-442.
    View in: PubMed
    Score: 0.197
  21. The concepts of asthma endotypes and phenotypes to guide current and novel treatment strategies. Expert Rev Respir Med. 2018 09; 12(9):733-743.
    View in: PubMed
    Score: 0.195
  22. Staphylococcus aureus enhances the tight junction barrier integrity in healthy nasal tissue, but not in nasal polyps. J Allergy Clin Immunol. 2018 08; 142(2):665-668.e8.
    View in: PubMed
    Score: 0.189
  23. Human CD40 ligand-expressing type 3 innate lymphoid cells induce IL-10-producing immature transitional regulatory B cells. J Allergy Clin Immunol. 2018 07; 142(1):178-194.e11.
    View in: PubMed
    Score: 0.184
  24. Advances and highlights in allergen immunotherapy: On the way to sustained clinical and immunologic tolerance. J Allergy Clin Immunol. 2017 Nov; 140(5):1250-1267.
    View in: PubMed
    Score: 0.184
  25. Mechanisms of immune regulation in allergic diseases: the role of regulatory T and B cells. Immunol Rev. 2017 07; 278(1):219-236.
    View in: PubMed
    Score: 0.181
  26. Type 2 innate lymphoid cells disrupt bronchial epithelial barrier integrity by targeting tight junctions through IL-13 in asthmatic patients. J Allergy Clin Immunol. 2018 01; 141(1):300-310.e11.
    View in: PubMed
    Score: 0.178
  27. International Consensus on Allergen Immunotherapy II: Mechanisms, standardization, and pharmacoeconomics. J Allergy Clin Immunol. 2016 Feb; 137(2):358-68.
    View in: PubMed
    Score: 0.164
  28. Transcription factors RUNX1 and RUNX3 in the induction and suppressive function of Foxp3+ inducible regulatory T cells. J Exp Med. 2009 Nov 23; 206(12):2701-15.
    View in: PubMed
    Score: 0.107
  29. COVID-19 pandemic: Practical considerations on the organization of an allergy clinic-An EAACI/ARIA Position Paper. Allergy. 2021 03; 76(3):648-676.
    View in: PubMed
    Score: 0.058
  30. Considerations on biologicals for patients with allergic disease in times of the COVID-19 pandemic: An EAACI statement. Allergy. 2020 11; 75(11):2764-2774.
    View in: PubMed
    Score: 0.057
  31. Immunology of COVID-19: Mechanisms, clinical outcome, diagnostics, and perspectives-A report of the European Academy of Allergy and Clinical Immunology (EAACI). Allergy. 2020 10; 75(10):2445-2476.
    View in: PubMed
    Score: 0.057
  32. ARIA-EAACI statement on asthma and COVID-19 (June 2, 2020). Allergy. 2021 03; 76(3):689-697.
    View in: PubMed
    Score: 0.056
  33. Cabbage and fermented vegetables: From death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID-19. Allergy. 2021 03; 76(3):735-750.
    View in: PubMed
    Score: 0.056
  34. Clinical characteristics of 182 pediatric COVID-19 patients with different severities and allergic status. Allergy. 2021 02; 76(2):510-532.
    View in: PubMed
    Score: 0.056
  35. Clinical, radiological, and laboratory characteristics and risk factors for severity and mortality of 289 hospitalized COVID-19 patients. Allergy. 2021 02; 76(2):533-550.
    View in: PubMed
    Score: 0.056
  36. Is diet partly responsible for differences in COVID-19 death rates between and within countries? Clin Transl Allergy. 2020; 10:16.
    View in: PubMed
    Score: 0.055
  37. Distinct characteristics of COVID-19 patients with initial rRT-PCR-positive and rRT-PCR-negative results for SARS-CoV-2. Allergy. 2020 07; 75(7):1809-1812.
    View in: PubMed
    Score: 0.055
  38. Eleven faces of coronavirus disease 2019. Allergy. 2020 07; 75(7):1699-1709.
    View in: PubMed
    Score: 0.055
  39. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020 07; 75(7):1730-1741.
    View in: PubMed
    Score: 0.054
  40. Blocking histone deacetylase activity as a novel target for epithelial barrier defects in patients with allergic rhinitis. J Allergy Clin Immunol. 2019 11; 144(5):1242-1253.e7.
    View in: PubMed
    Score: 0.051
  41. Human bocaviruses and paediatric infections. Lancet Child Adolesc Health. 2019 06; 3(6):418-426.
    View in: PubMed
    Score: 0.051
  42. Control of Confounding and Reporting of Results in Causal Inference Studies. Guidance for Authors from Editors of Respiratory, Sleep, and Critical Care Journals. Ann Am Thorac Soc. 2019 01; 16(1):22-28.
    View in: PubMed
    Score: 0.050
  43. microRNA-146a is linked to the production of IgE in mice but not in atopic dermatitis patients. Allergy. 2018 12; 73(12):2400-2403.
    View in: PubMed
    Score: 0.049
  44. Development and characterization of DNAzyme candidates demonstrating significant efficiency against human rhinoviruses. J Allergy Clin Immunol. 2019 04; 143(4):1403-1415.
    View in: PubMed
    Score: 0.049
  45. Relations between epidermal barrier dysregulation and Staphylococcus species-dominated microbiome dysbiosis in patients with atopic dermatitis. J Allergy Clin Immunol. 2018 11; 142(5):1643-1647.e12.
    View in: PubMed
    Score: 0.049
  46. Tonsillar cytokine expression between patients with tonsillar hypertrophy and recurrent tonsillitis. Clin Transl Allergy. 2018; 8:22.
    View in: PubMed
    Score: 0.048
  47. A Fluorescent Probe to Unravel Functional Features of Cannabinoid Receptor CB1 in Human Blood and Tonsil Immune System Cells. Bioconjug Chem. 2018 02 21; 29(2):382-389.
    View in: PubMed
    Score: 0.047
  48. Ozone exposure induces respiratory barrier biphasic injury and inflammation controlled by IL-33. J Allergy Clin Immunol. 2018 09; 142(3):942-958.
    View in: PubMed
    Score: 0.047
  49. Microbiome and asthma. Asthma Res Pract. 2018; 4:1.
    View in: PubMed
    Score: 0.047
  50. Food allergy: Update on prevention and tolerance. J Allergy Clin Immunol. 2018 01; 141(1):30-40.
    View in: PubMed
    Score: 0.046
  51. Transforming growth factor-ß1 decreases epithelial tight junction integrity in chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol. 2018 03; 141(3):1160-1163.e9.
    View in: PubMed
    Score: 0.046
  52. Evanescence wave-based technology for the rapid and sensitive quantification of biological analytes. J Allergy Clin Immunol. 2018 02; 141(2):817-820.e5.
    View in: PubMed
    Score: 0.046
  53. Histamine and T helper cytokine-driven epithelial barrier dysfunction in allergic rhinitis. J Allergy Clin Immunol. 2018 03; 141(3):951-963.e8.
    View in: PubMed
    Score: 0.046
  54. Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis. Nat Commun. 2017 09 19; 8(1):593.
    View in: PubMed
    Score: 0.046
  55. Immune regulation by histamine and histamine-secreting bacteria. Curr Opin Immunol. 2017 Oct; 48:108-113.
    View in: PubMed
    Score: 0.046
  56. Exposure to nonmicrobial N-glycolylneuraminic acid protects farmers' children against airway inflammation and colitis. J Allergy Clin Immunol. 2018 01; 141(1):382-390.e7.
    View in: PubMed
    Score: 0.045
  57. miR-146b Probably Assists miRNA-146a in the Suppression of Keratinocyte Proliferation and Inflammatory Responses in Psoriasis. J Invest Dermatol. 2017 09; 137(9):1945-1954.
    View in: PubMed
    Score: 0.045
  58. Clinical phenotypes and endophenotypes of atopic dermatitis: Where are we, and where should we go? J Allergy Clin Immunol. 2017 Apr; 139(4S):S58-S64.
    View in: PubMed
    Score: 0.044
  59. The effects of cryopreservation on the expression of canine regulatory T-cell markers. Vet Dermatol. 2017 Aug; 28(4):396-e93.
    View in: PubMed
    Score: 0.044
  60. Segmental duplications and evolutionary acquisition of UV damage response in the SPATA31 gene family of primates and humans. BMC Genomics. 2017 03 06; 18(1):222.
    View in: PubMed
    Score: 0.044
  61. The relationship of serum vitamins A, D, E and LL-37 levels with allergic status, tonsillar virus detection and immune response. PLoS One. 2017; 12(2):e0172350.
    View in: PubMed
    Score: 0.044
  62. A wide diversity of bacteria from the human gut produces and degrades biogenic amines. Microb Ecol Health Dis. 2017; 28(1):1353881.
    View in: PubMed
    Score: 0.044
  63. A Th17- and Th2-skewed cytokine profile in cystic fibrosis lungs represents a potential risk factor for Pseudomonas aeruginosa infection. Am J Respir Crit Care Med. 2013 Mar 15; 187(6):621-9.
    View in: PubMed
    Score: 0.033
  64. Portrait of an immunoregulatory Bifidobacterium. Gut Microbes. 2012 May-Jun; 3(3):261-6.
    View in: PubMed
    Score: 0.032
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.